Estimating direct medical costs of type 2 diabetes mellitus in the Philippines: a protocol

Abstract

IntroductionDiabetes and its complications are a major cause of morbidity and mortality in the Philippines. The prevalence of diabetes in the Philippines has increased from 3.4 million in 2010 to 3.7 million in 2017. The government has formulated strategies to control this increase, for example, through its non-communicable disease prevention and control plan. However, there is scarce research on the financial burden of diabetes. Filling this gap may further help policymakers to make informed decisions while developing and implementing resource planning for relevant interventions. The primary objective of the current study is to estimate the direct medical costs associated with type 2 diabetes mellitus (T2DM).Methods and analysisThis is a 1-year retrospective cohort study of patients with T2DM in 2016. Data will be collected from: (1) hospital databases from public institutions to estimate the cost of diabetes treatment and (2) physician interviews to estimate the cost of management of diabetes in outpatient care. We will perform descriptive and comparative analyses on direct medical costs and healthcare resource utilisation, stratified by the presence of diabetes-associated complications.Ethics and disseminationResearch ethics board approval has been obtained from the Department of Health Single Joint Research Ethics Board and Cardinal Santos Medical Center Research Ethics Review Committee. Findings from the study will be reported in peer-reviewed scientific journals and local researcher meetings.

Impacto económico de desbridamientos quirúrgicos y amputaciones de miembros inferiores en pacientes diabéticos

“…A nivel mundial la prevalencia de DM2 representa gastos totales anuales que van desde USD 141,6 millones 174 mil millones (6) , de acuerdo a los datos del Ministerio de Salud Pública y Bienestar Social en Paraguay en el año 2015 el tratamiento total de cada paciente diabético en el sector privado tiene un costo aproximado de más de 3 millones de guaraníes al año (7,8) , con este trabajo se puede estimar un costo total anual de USD 262.541, teniendo en cuenta solamente el tratamiento quirúrgico de las complicaciones de esta patología en nuestro centro hospitalario (9,10) .…”

Direct medical costs of type 2 diabetes mellitus in the Philippines: findings from two hospital databases and physician surveys

“…The study methodology has been published. 15 Briefly, the estimation of direct medical cost of T2DM involved two parts: (1) a retrospective cohort study design using electronic records from two hospitals and (2) a crosssectional survey with 50 physicians. The first part was used to estimate the direct medical costs of people with T2DM-related complications, and the latter was aimed to describe the management cost for those without complications and were routinely followed up at outpatient care.…”

Mapping the Journey of Patients with Painful Diabetic Peripheral Neuropathy in the Philippines

“…2 The direct diabetes-related expenditure per person is estimated at around USD 428, and indirect expenditure at USD1,136 per person in the Philippines, indicating a growing financial burden. 3 Diabetic peripheral neuropathy (DPN) is a frequent microvascular complication of diabetes, resulting in high morbidity and mortality. Oxidative stress caused by AGE (advanced glycation end-products) is responsible for microscopic vascular damage hindering blood supply to the peripheral nerves.…”